A number of advancements have been made in algal technology in different fields, such as medical, cosmetic, and pharmaceutical. Green algae (Chlorophyta) are a group of photosynthetic organisms which live in both aquatic and terrestrial environments. They are a potential source of bioactive compounds for the treatment and prevention of a wide range of infectious diseases caused by microorganisms. These compounds also possess anti-inflammatory, antioxidant, anticoagulant, antitumor, and immunomodulatory properties. A wide variety of bioactive compounds are produced, including polysaccharides, which exhibit antimicrobial properties capable of interfering with the cell walls, membranes, and nucleic acids of microorganisms. Membrane fluidity, permeability, or integrity can be affected by polyphenols and fatty acids which scavenge free radicals, chelate metal ions, or disrupt enzymes and membranes. Proteins and peptides form pores within the membranes which bind to specific receptors or inhibit enzymes. Adaptation to adverse environmental conditions, such as temperature extremes, photooxidation, salinity, or osmotic stress, results in the formation of bioactive compounds by altering the physiological and biochemical pathways of algae for the maintenance of cellular homeostasis. With changing consumer preferences and an increase in the number of resistant microorganisms, it is critical to seek novel antimicrobial compounds from green algae. The search for novel bioactive compounds with antimicrobial properties from green algae may serve as an alternative in the light of increased drug resistance in microorganisms. However, in vitro and in vivo evaluations of the safety, efficacy, and mechanism of action of the antimicrobial compounds from green algae require more research. Providing an overview of previous endeavours in this emerging field, this review provides perspectives and a summary of the bioactive compounds responsible for the antimicrobial properties of green algal extracts.
Read full abstract